$67.36
0.52 (+0.78%)
Amgen, Inc. (NASDAQ:AMGN)
CAPS Rating:
A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.
A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.